Clinical Trial Update: A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating activity of robatumumab (MK-7454) in relapsed or recurrent colorectal cancer; study completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• MK-7454 (robatumumab)
• SCH 717454 (robatumumab)
• robatumumab (robatumumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-12-15